SENSEX NIFTY

Drugs

Jul 25, 2014 at 21:22 | Source: CNBC-TV18
The pressure is building up on the Indian drug regulator to clampdown on the fake drugs that are inundating the Indian market. A desperate CDSCO has decided to restart an old scheme -- reward to any whistleblower who is instrumental in the seizure of counterfeit drugs and cosmetics.
Jul 25, 2014 at 15:37 | Source: Moneycontrol.com
Parabolic Drugs Ltd has informed BSE that Mr. Balbir Singh Bhasin, Nominee Director of State Bank of India (SBI) has resigned from the Board of Directors of the Company w.e.f. July 02, 2014.
Jul 24, 2014 at 19:13 | Source: PTI
The licensing agreement extends Ranbaxy's current relationship with Cipher, under which it is marketing isotretinoin capsules in the US under the brand 'Absorica', Ranbaxy Laboratories said in a statement.
Jul 24, 2014 at 12:57 | Source: Moneycontrol.com
After inspecting the companys active pharmaceutical ingredients (APIs) manufacturing unit at Raltam, US Food and Drug Administration (US FDA) has raised some concerns in Form 483. Hence the drug manufacturer will suspend shipments to the US markets till the issue is addressed.
Jul 23, 2014 at 21:19 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals board meeting will be held on July 30, 2014, to transact the items of business thereat to review the performance of the Company and Consider, approve and take on record the unaudited financial results for the quarter ended June 30, 2014.
Jul 23, 2014 at 16:59 | Source: Moneycontrol.com
Venmax Drugs and Pharmaceuticals has board meeting will be held on July 28, 2014, to consider the following : 1. To consider and take note of the Unaudited financial results for the quarter ended June 30, 2014. 2. To review the working of the Company. 3. To decide the date of AGM for the Year 2013-14.
Jul 23, 2014 at 16:20 | Source: PTI
The capsule is an immuno-suppressant used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.
Jul 23, 2014 at 11:35 | Source: Moneycontrol.com
Strides Arcolab today announced that it has received approval from the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg.
Jul 23, 2014 at 10:42 | Source: Moneycontrol.com
With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to come under pressure, says an ICRA report.
Jul 22, 2014 at 18:21 | Source: Reuters
GSK is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of off-patent drugs marketed in North America and western Europe with annual sales of around 1 billion pounds (USD 1.7 billion).
Messages on Drugs »

maximindia

Platinum Member

524 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th

Market Statistician

Platinum Member

9330 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th

News across the web »
Jul 25, 2014 at 15:59 | Source: NDTV Profit
Jul 25, 2014 at 12:20 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.